GEJ ADENOCARCINOMA

Clinical trials for GEJ ADENOCARCINOMA explained in plain language.

Never miss a new study

Get alerted when new GEJ ADENOCARCINOMA trials appear

Sign up with your email to follow new studies for GEJ ADENOCARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 3 Not yet recruiting 2 Not yet finished but already full! 1

New drug cocktail shows promise for Hard-to-Treat gut cancers

Disease control Ongoing

This study is testing a drug called tucatinib combined with other cancer medicines (trastuzumab, chemotherapy, and pembrolizumab) in people with HER2-positive cancers of the digestive system. The main goals are to find safe doses and see what side effects occur. About 40 adults w…

Matched conditions: GEJ ADENOCARCINOMA

Phase: PHASE2 • Sponsor: Seagen, a wholly owned subsidiary of Pfizer • Aim: Disease control

Last updated Jun 27, 2026 09:07 UTC

GEJ ADENOCARCINOMA

Get alerted when new GEJ ADENOCARCINOMA trials appear

New drug cocktail shows promise for Hard-to-Treat gut cancers